Outcomes research in rheumatic diseases

风湿性疾病的结果研究

• 批准号: 8348789
• 负责人: DINESH KHANNA
• 金额: $ 17.96万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-01 至 2017-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8348789
• 关键词: 25-hydroxyvitamin D; Acute-Phase Proteins; Address; Area; Arthritis; Autoantibodies; Biological Markers; Biometry; Blood; Blood capillaries; Characteristics; Chest; Clinical; Clinical Investigator; Clinical Research; Clinical Trials; Clinical Trials Design; Cognitive; Collaborations; Committee Members; Consensus; Cutaneous; Cyclophosphamide; Data; Databases; Development; Diffuse; Diffuse Scleroderma; Dyspnea; Ensure; Environment; Faculty; Fibromyalgia; Fibrosis; Focus Groups; Funding; Future; Gastrointestinal Diseases; Genetic; Goals; Gout; Grant; Inflammation; Information Systems; Interstitial Lung Diseases; Interview; Joints; Literature; Lung; Measurement; Measures; Mediator of activation protein; Medical; Mentors; Michigan; Mid-Career Clinical Scientist Award (K24); Modeling; Molecular; Mycophenolate; Nail Fold; National Heart, Lung, and Blood Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Observational Study; Oral; Outcome Measure; Outcomes Research; Patient Outcomes Assessments; Patients; Physiological; Placebos; Property; Psychometrics; Randomized Controlled Trials; Registries; Reporting; Research; Research Methodology; Research Personnel; Research Project Grants; Research Support; Research Training; Resolution; Resources; Rheumatism; Rheumatoid Arthritis; Rheumatology; Role; Scleroderma; Secure; Serological; Serum; Skin; Structure; Students; Swelling; Systemic Lupus Erythematosus; Systemic Scleroderma; Taxonomy; Techniques; Time; Tissues; Training; Training Programs; United States National Institutes of Health; Universities; Validation; Vascular Diseases; Vitamin D; Work; X-Ray Computed Tomography; biobank; biopsychosocial; capillary; clinical phenotype; cohort; experience; gastrointestinal symptom; indexing; interest; mycophenolate mofetil; patient oriented research; programs; prospective; repository; response; systematic review; theories; trial comparing

DESCRIPTION (provided by applicant): Outcomes research in rheumatic diseases The goals of the K24 application are to support my continued development and impact as a mentor, to establish a research training program for patient-oriented research (POR) in the Division of Rheumatology at the University of Michigan (UM), and to expand my current POR program. In the past few years, I have actively mentored trainees and junior faculty on different POR projects and the immediate objective of the proposed K24 is to secure protected time to continue my efforts and develop future clinical investigators with a focus on patient-reported outcome measures and trial design in rheumatic diseases. In addition to directing a large Scleroderma program, I continue to work extensively in other arthritides (gout and rheumatoid arthritis) and have support of established clinical researchers in systemic lupus erythematosus and fibromyalgia, providing a rich environment of POR at UM. Given my commitment to mentoring, recent collaborations with the UM Department of Biostatistics, UM's rich resources dedicated to POR, and strong institutional support to create this program, the K24 Award provides an invaluable opportunity to expand my mentoring efforts and to establish a specialized structured POR program. The program will ensure that medical and biostatistical students and fellows interested in becoming independent investigators will be supported by an interdisciplinary team of mentors and will acquire training in clinical research methods and biostatistics. K24 grant would preserve my time at 50% effort and relieve future clinical and administrative responsibilities. A diverse portfolio of currently funded research opportunities exists for future trainees in POR. Research proposed includes two current projects and two new projects addressing POR areas of patient reported outcomes, clinical trial design, and database development. The two current NIH funded studies include: 1. To develop and evaluate the psychometric properties of gastrointestinal symptoms item bank developed under the NIH Patient-Reported Outcomes Measurement Information System initiative; and 2. To develop a combined response index for scleroderma clinical trials in an ongoing NIH funded longitudinal observational study. The aims of two new proposed studies are: 1. To determine the relationship between the vitamin D status and physiological, radiological, and dyspnea measures of scleroderma-associated interstitial lung disease (SSc-ILD) in an ongoing NIH funded clinical trial comparing oral mycophenolate mofetil vs. oral cyclophosphamide in 150 patients with active SSc-ILD. 2. To develop an early diffuse scleroderma observational registry through the coordinated efforts of several young investigators at large U.S. scleroderma centers. The goals of the registry include: i) to determine whether the clinical phenotypes and autoantibodies at baseline in early, diffuse scleroderma are associated with, and predict, clinical, radiological, and patient-reported outcomes and survival; and ii) to develop a repository of scleroderma blood and tissue to explore the cellular and molecular mediators of SSc and their association with clinical phenotypes and autoantibodies. PUBLIC HEALTH RELEVANCE The goals of the K24 application are to support my continued development as a mentor and to establish a research training program for patient oriented research. The proposed program is interdisciplinary, and focuses in expanding clinical research opportunities and mentoring in rheumatic diseases. The K24 Award would ensure that I have the protected time to be able to expand my current mentoring activities while continuing to advance my patient oriented research program in patients with rheumatic disease. Research includes two current projects and two new projects addressing patient-oriented research areas of patient-reported outcomes, clinical trial design, and database development.

描述（由申请人提供）：风湿性疾病的成果研究K24申请的目标是支持我作为导师的持续发展和影响，在密歇根大学（UM）的流变学部门建立以患者为导向的研究（POR）的研究培训计划，并扩大我目前的POR计划。在过去的几年里，我积极指导学员和初级教师进行不同的POR项目，拟议的K24的直接目标是确保有保护的时间继续我的努力，并培养未来的临床研究者，重点是患者报告的结果测量和风湿性疾病的试验设计。除了指导一个大型硬皮病计划，我继续在其他关节炎（痛风和类风湿性关节炎）广泛工作，并在系统性红斑狼疮和纤维肌痛的既定临床研究人员的支持下，在UM提供丰富的POR环境。鉴于我对指导的承诺，最近与UM生物统计学系的合作，UM致力于POR的丰富资源，以及创建此计划的强大机构支持，K24奖提供了一个宝贵的机会来扩大我的指导工作，并建立一个专门的结构化POR计划。该计划将确保有兴趣成为独立调查员的医学和生物统计学学生和研究员将得到跨学科导师团队的支持，并将获得临床研究方法和生物统计学的培训。K24补助金将节省我50%的时间，并减轻未来的临床和行政责任。目前资助的研究机会的多样化组合存在未来的学员在POR。拟议的研究包括两个当前项目和两个新项目，涉及患者报告结局、临床试验设计和数据库开发的POR领域。目前NIH资助的两项研究包括：1。开发和评估在NIH患者报告结果测量信息系统倡议下开发的胃肠道症状项目库的心理测量特性;和2.在一项正在进行的NIH资助的纵向观察性研究中，为硬皮病临床试验开发一个联合反应指数。两项新研究的目的是：1。旨在确定维生素D状态与硬皮病相关间质性肺病（SSc-ILD）的生理学、放射学和呼吸困难指标之间的关系，该研究正在进行中，由NIH资助，在150例活动性SSc-ILD患者中比较口服吗替麦考酚酯与口服环磷酰胺。2.通过美国大型硬皮病中心几位年轻研究者的协调努力，开发早期弥漫性硬皮病观察登记。该登记研究的目的包括：i）确定早期弥漫性硬皮病患者基线时的临床表型和自身抗体是否与临床、放射学和患者报告的结局和生存率相关，并预测这些结局和生存率; ii）建立一个储存库 的硬皮病血液和组织，探讨SSc的细胞和分子介质及其与临床表型和自身抗体的关联。 公共卫生相关性K24应用程序的目标是支持我作为导师的持续发展，并为面向患者的研究建立研究培训计划。该计划是跨学科的，重点是扩大风湿性疾病的临床研究机会和指导。K24奖将确保我有受保护的时间来扩大我目前的指导活动，同时继续推进我在风湿性疾病患者中以患者为导向的研究计划。研究包括两个当前项目和两个新项目，涉及患者报告结局，临床试验设计和数据库开发的以患者为导向的研究领域。